Screener
Cytek Biosciences, Inc. CTKB Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s total debt?
- Cytek Biosciences, Inc. (CTKB) reported total debt of $17.03M in Q2 2026.
- How has Cytek Biosciences, Inc.'s total debt changed year-over-year?
- Cytek Biosciences, Inc.'s total debt decreased by 6.6% year-over-year, from $18.24M to $17.03M.
- What is the long-term trend for Cytek Biosciences, Inc.'s total debt?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s total debt has grown at a 3.5% compound annual growth rate (CAGR), from $15.2M to $17.45M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Cytek Biosciences, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude